Hirsch Andrew

Hirsch Andrew is listed in filings as President & CEO at C4 Therapeutics, Inc.. This profile follows SEC Form 4 activity through Feb 18, 2026, including 14 public disclosures. Recent filings connect the profile to C4 Therapeutics, Inc. (CCCC) and Editas Medicine Inc (EDIT). The current snapshot covers public activity from Sep 17, 2024 to Feb 18, 2026. Reported amounts are shown as $17.1K to $71.6K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.